{
  "ticker": "EBR",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976922",
  "id": "02976922",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250805",
  "time": "0921",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjvvv8jrbqb6.pdf",
  "summary": "- **NTAP Approval**: CMS approved maximum NTAP reimbursement of **US$41,145** per WiSE\u00ae System for Medicare inpatients, in addition to DRG payments.  \n- **Effective Date**: NTAP reimbursement commences **1 October 2025**, aligning with initial limited market release.  \n- **Duration**: NTAP validity for **3 years**; EBR to petition for full DRG coverage in Year 2.  \n- **Outpatient TPT Approval**: Expected final approval for Transitional Pass-Through (TPT) payments in outpatient settings by **1 October 2025**.  \n\n*Material impact*: Reimbursement pathway secured, enhancing commercial viability and adoption prospects in U.S. markets.  \n\n*(No other material information identified)*.",
  "usage": {
    "prompt_tokens": 1935,
    "completion_tokens": 158,
    "total_tokens": 2093,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-04T23:52:05.098387"
}